Life Science Company and Industry News Briefs

In the past 4 years the University of California, Riverside has achieved a great deal in life science research development. It has gained substantial ground in terms of the depth and breadth of its research programs, especially since the opening of its new medical school four years ago. 

Biotechnology Calendar, Inc.’s San Diego lab product expo is less than a month away, and spaces are selling out quickly. Currently, we have nine spaces left for this premium life science marketing opportunity, where you will meet researchers, purchasing agents and lab managers with the funding available to make informed lab technology decisions and have the opportunity to sell lab products within this highly funded market.

The University of Alabama at Birmingham is a thriving research environment that lab suppliers can take full advantage of. Biotechnology Calendar Inc.’s 13^th Annual Bioresearch Product Faire™ at UAB on November 14^th, 2013 is a tremendous opportunity to increase a company’s sales and brand exposure, as well as network with lead researchers at this well-funded university.

Researchers at Harvard University were recently awarded $2.1 million by the NIH for a project titled “Dissecting the Establishment and Regulation of Human Pluripotency.” The NIH RePORTER describes in detail the specifics of the project in the project’s abstract, written by the Harvard researchers:

“In 2007, the University of Alabama at Birmingham (DAB) and its affiliates completed three important, large- scale strategic planning efforts. Together, these processes generated a ‘blueprint for our research future’ that lays the foundation to transform our substantial clinical and translational research enterprise through integration and innovation across all disciplines, schools, and our health care system,” says the University of Alabama’s abstract for its Center for Clinical and Translational Science on the NIH RePORTER. The Center for Clinical and Translational Science received a $5.1 million award last year.

Researchers at Stony Brook University, led by Samuel Stanley, applied for NIH funding to build an animal biosafety level three laboratory and received $14.2 million this year. Stony Brook University is one of the leading research universities in the country. According to the Stony Brook website, the university employs over 1000 researchers working on 1600 active sponsored projects. Stony Brook aims to collaborate in research partnerships that bring about new knowledge in all fields of research and scholarly activity The NIH RePORTER has details on some of the project information for the new laboratory receiving NIH funding:

Researchers at Rockefeller University, led by Dr. Gaby Maimon, recently received NIH funding for their studies of fruit flies’ neuronal activity in decision-making, which they believe has the potential to impact pharmaceuticals for human mental illness. According to the Rockefeller University website, Dr. Maimon’s research team aims to “link the electrical activity of neurons and the biochemical action of molecules to their computational roles in animal behavior. The lab has a particular interest in understanding how central brain structures, distant from the sensory and motor periphery, govern behavioral choice.” The latest research grant money has been given to an ongoing project titled “Linking Genes to Higher Brain Function by Way of Cellular Electrophysiology.” The project received $2.5 million from the NIH. The NIH RePORTER details the goals of the project in an abstract posted online:

Researchers at the University of Arizona’s Arizona Cancer Center received a $3.7 million renewal of funding this year for cancer research. Led by David Alberts, who, according to the University of Arizona website, has made his career’s focus researching translational cancer prevention and treatment, the center was awarded the research funding by the NIH earlier this year. Alberts’ research teams work in laboratory-based and clinical research settings studying the chemoprevention and treatment of breast cancer, colon cancer, ovary cancer and skin cancer. The NIH RePORTER provides more information on the Arizona Cancer Center in the funding abstract:

Researchers at Rockefeller University received a $1.9 million NIH grant this year for the project “Identification of Cell Type-Specific Actions of Antipsychotic Drugs.” The study is being led by Paul Greengard, PhD. According to the Rockefeller University webpage, Greengard’s research aims are to understand the molecular basis of communication between neurons in the brain in mammals, clarify the molecular defects responsible for a number of neurological and psychiatric disorders and determine the molecular mechanisms by which neuro- and psychoactive drugs produce their pharmacological actions.

Lab suppliers marketing life science products and lab products in California may want to take a closer look at the wealth of funding available at the University of California, Los Angeles. Biotechnology Calendar, Inc. has put together an article spotlighting NIH, NSF and other research funding statistics at the university that prove how well funded the University of California, Los Angeles market is. If these funding statistics sound attractive, Biotechnology Calendar, Inc. encourages lab suppliers to consider attending our UCLA life science marketing events.